Page 31 - U11248 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from U11248. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In U11248 Today - Breaking & Trending Today

Etoposide Plus Trastuzumab Shows Benefit in Metastatic BCa

The median overall survival was 11.3 months in heavily pretreated women with metastatic disease. The study was published as a preprint and has not yet been peer reviewed. ....

Saint Cloud , France General , Institut Curie Hospitals , Metastatic Breast Carcinoma , Antineoplastic Drug , Nti Cancer Agents , Peer Review ,

FDA Hints at Deadlines to Meet Accelerated Approval Requirements

Three physicians with the FDA are suggesting that it might be time to give drug companies a deadline to meet accelerated approval requirements, as is done in other countries. ....

United States , Richard Pazdur , Gautamu Mehta , Oncology Center , Drug Administration , Global Clinical Sciences , Medscape Professional Network , Drug Evaluation , Clinical Sciences , Medscape Professional , Us Food And Drug Administration , Nited States Food And Drug Administration , Antineoplastic Drug , Nti Cancer Agents ,

5 Things to Know About PBMs

Pharmacy benefit managers, who have come to dominate the prescription drug world in the US, use a range of abusive tactics to dictate how expensive oncology drugs are covered and paid for. ....

New York , United States , West Virginia , Frier Levitt , Adam Fein , Jonas Congelli , Ted Okon , Martha Rumore , Jesse Dresser , Avalere Health , Centers For Medicare Medicaid Services , National Community Pharmacists Association , American Society Of Clinical Oncology , Care Management Association , Community Oncology Alliance , Unitedhealth Group , York State Senate , Drug Channels Institute , Rural Policy Research Institute , Oncology Associates Of Central New York , Express Scripts , Pharmaceutical Care Management Association , Drug Channels , New York City , Hematology Oncology Associates , Central New York ,

Breast Cancer Trials Enrolling Now: Could Your Patient Benefit?

Maybe one of your patients could benefit from clinical trials that are currently recruiting patients with breast cancer. ....

South Carolina , United States , Kathy Miller , University Of Kansas Medical Center , National Cancer Institute , Indiana University School Of Medicine , Drug Administration , Kansas Medical Center , Indiana University School , Breast Cancer , Alignant Breast Neoplasm , Alignant Neoplasia , Her2 Positive Breast Cancer , Her2 Breast Cancer , Antineoplastic Drug , Nti Cancer Agents , Clinical Research , Clinical Trials , Linical Studies , Endocrine Therapy , Healthcare And Medical Technology , Ealth And Medical Tech ,

Promising Combo for HER2-Positive Breast Cancer Brain Metastases

In women with HER2 (ERBB2)-positive breast cancer brain metastases, combination therapy with pyrotinib and capecitabine elicited an intracranial response in a phase 2 trial. ....

New York , United States , Kazuaki Takabe , Roswell Park Comprehensive Cancer Center , Reuters Health , Jiangsu Hengrui Pharmaceuticals , Eastern Cooperative Oncology Group , Lancet Oncology , Thomas Bachelot , Unicancer National Breast Cancer Group , Jiangsu Hengrui , Breast Cancer , Alignant Breast Neoplasm , Brain Metastasis , Metastatic Brain Tumor , Malignant Head And Neck Neoplasm , Brain Cancer , Alignant Brain Neoplasm , Radiation Oncology , Her2 Positive Breast Cancer , Her2 Breast Cancer , Her2 Neu , Antineoplastic Drug , Nti Cancer Agents , Biologic Therapy ,